Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neridronate vs placebo for transient osteoporosis of the hip
2018-003505-26Phase 3Terminated
- Sponsor
- Abiogen Pharma
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Transient Osteoporosis Of The Hip (TOH) comparing Neridronate arm with Placebo arm (2 arms). Started Jan 2021; status: terminated.
02
Drugs
neridronic acid
03
Conditions
Transient Osteoporosis Of The Hip (TOH)
Beyond the preview
Go deeper on 2018-003505-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003505-26.